Raiffeisen Bank International Ag Biotechnology

Raiffeisen Bank International Ag

  • $7.54 Trillion
  • Q3 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
VRTX
Vertex Pharmaceuticals Inc
CALL
$338 Million
863
Q3 2025
Reduced 1.17%
CORT
Corcept Therapeutics Inc
CALL
$166 Million
2K
Q4 2024
New holding
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$165 Million
294
Q3 2025
Added 10.36%
EXEL
Exelixis, Inc.
CALL
$124 Million
3K
Q4 2024
New holding
IONS
Ionis Pharmaceuticals Inc
CALL
$115 Million
1.75K
Q3 2025
Reduced 11.9%
AXSM
Axsome Therapeutics, Inc.
CALL
$72.9 Million
600
Q4 2024
New holding
INCY
Incyte Corp
CALL
$42.4 Million
500
Q3 2025
Reduced 55.8%
BMRN
Biomarin Pharmaceutical Inc
CALL
$37.7 Million
696
Q3 2025
Added 22.26%
EDIT
Editas Medicine, Inc.
CALL
$34.7 Million
10K
Q4 2024
New holding
NTLA
Intellia Therapeutics, Inc.
CALL
$34.5 Million
2K
Q4 2024
New holding
SRPT
Sarepta Therapeutics, Inc.
CALL
$28.2 Million
1.47K
Q3 2025
Added 8.53%
ARCT
Arcturus Therapeutics Holdings Inc.
CALL
$24.3 Million
1.32K
Q4 2024
New holding
ARWR
Arrowhead Pharmaceuticals, Inc.
CALL
$17.2 Million
500
Q4 2024
New holding
IOVA
Iovance Biotherapeutics, Inc.
CALL
$4.34 Million
2K
Q3 2025
Added 63.27%
ALLO
Allogene Therapeutics, Inc.
CALL
$2.48 Million
2K
Q3 2025
Added 11.94%
ADAP
Adaptimmune Therapeutics PLC
CALL
$118,000
907
Q4 2024
New holding
Filter Shares Options
Track This Portfolio

Track Raiffeisen Bank International Ag Portfolio

Follow Raiffeisen Bank International Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raiffeisen Bank International Ag, based on Form 13F filings with the SEC.

News

Stay updated on Raiffeisen Bank International Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email